Terms: = Liver cancer AND LCP1, CP64, 3936, ENSG00000136167, FLJ39956, DKFZp781A23186, L-PLASTIN, FLJ25423, P13796, FLJ26114, PLS2, LC64P
6 results:
1. Evaluation of liver parenchyma stiffness in patients with liver tumours: optimal strategy for shear wave elastography.
Zheng W; Zhou ZG; Wong CH; Pei XQ; Zhuang SL; Li Q; Chen MS; Li AH; Zhang FJ
Eur Radiol; 2019 Mar; 29(3):1479-1488. PubMed ID: 30105408
[TBL] [Abstract] [Full Text] [Related]
2. Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.
Yanik EL; Chinnakotla S; Gustafson SK; Snyder JJ; Israni AK; Segev DL; Engels EA
Liver Transpl; 2016 May; 22(5):627-34. PubMed ID: 26784951
[TBL] [Abstract] [Full Text] [Related]
3. Comparative secretome analysis of cholangiocarcinoma cell line in three-dimensional culture.
Tit-Oon P; Chokchaichamnankit D; Khongmanee A; Sawangareetrakul P; Svasti J; Srisomsap C
Int J Oncol; 2014 Nov; 45(5):2108-16. PubMed ID: 25189380
[TBL] [Abstract] [Full Text] [Related]
4. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.
Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Lee HJ; Eun JY; Kim HG; Yoon SS; Lee DS; Kim JH; Kim JR
Clin Exp Metastasis; 2008; 25(1):89-96. PubMed ID: 17992475
[TBL] [Abstract] [Full Text] [Related]
5. Cytotoxic effect of a replication-incompetent adenoviral vector with cytosine deaminase gene driven by l-plastin promoter in hepatocellular carcinoma cells.
Jung K; Kim S; Lee K; Kim C; Chung I
Arch Pharm Res; 2007 Jun; 30(6):770-7. PubMed ID: 17679557
[TBL] [Abstract] [Full Text] [Related]
6. cancer risk at sites other than the breast following augmentation mammoplasty.
Brinton LA; Lubin JH; Burich MC; Colton T; Brown SL; Hoover RN
Ann Epidemiol; 2001 May; 11(4):248-56. PubMed ID: 11306343
[TBL] [Abstract] [Full Text] [Related]
